| scholarly article | Q13442814 |
| P2093 | author name string | James Welch | |
| William F Simonds | |||
| Maria Merino | |||
| Sunita K Agarwal | |||
| Mari Suzuki | |||
| John Sharretts | |||
| Jaydira Del Rivero | |||
| Jenny E Blau | |||
| Rahul Lakhotia | |||
| Mark Ahlman | |||
| Sakshi Jhawar | |||
| P2860 | cites work | Lanreotide in metastatic enteropancreatic neuroendocrine tumors | Q28243728 |
| Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system | Q28262479 | ||
| A 5-decade analysis of 13,715 carcinoid tumors | Q34175374 | ||
| The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification | Q34321928 | ||
| ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations | Q37348914 | ||
| Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I. | Q37730726 | ||
| Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document | Q37881477 | ||
| Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors | Q38809059 | ||
| [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment | Q41011017 | ||
| A case of early-stage ovarian carcinoid tumor metastasized to the liver | Q42085107 | ||
| Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group | Q43286770 | ||
| Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy | Q47128709 | ||
| Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report | Q48519149 | ||
| Primary Ovarian Carcinoid: Extensive Clinical Experience With an Underrecognized Uncommon Entity. | Q50115353 | ||
| Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. | Q54256759 | ||
| Carcinoids associated with multiple endocrine neoplasia syndromes | Q69902407 | ||
| Carcinoids of the ovary: an analysis of 329 reported cases | Q73362434 | ||
| Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors | Q88613670 | ||
| Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials | Q89421027 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | multiple endocrine neoplasia | Q1553018 |
| neuroendocrine tumor | Q1981276 | ||
| multiple endocrine neoplasia type 1 | Q3347154 | ||
| P577 | publication date | 2019-08-20 | |
| P1433 | published in | Endocrinology, diabetes & metabolism case reports | Q27725324 |
| P1476 | title | Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1 | |
| P478 | volume | 2019 |
Search more.